A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study
Archives of Medical Science · 30.04.2026 · 22 (2) · 1224-1233
DOI: 10.5114/aoms/221117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Medical Science, online erschienen am 30.04.2026. Verfasst von Yu-Zhen Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Pharmacy, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
- Department of Pharmacy, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
- Department of Pharmacy, The First People's Hospital of Wuyi County, Jinhua, China.
Zitieren
APA
Wang, Y. Z., Hu, Q. Q., Xu, L. Y., Li, L. C., Xu, J. J., & Mao, K. L. (2026). A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study. Archives of Medical Science, 22(2), 1224-1233. https://doi.org/10.5114/aoms/221117
Vancouver
Wang YZ, Hu QQ, Xu LY, Li LC, Xu JJ, Mao KL. A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study. Archives of Medical Science. 2026;22(2):1224-1233. doi:10.5114/aoms/221117
BibTeX
@article{Wang2026,
author = {Wang, Yu-Zhen and Hu, Qing-Qing and Xu, Lu-Yao and Li, Liu-Cheng and Xu, Jun-Jie and Mao, Kai-Li},
title = {A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study},
journal = {Archives of Medical Science},
year = {2026},
volume = {22},
number = {2},
pages = {1224--1233},
doi = {10.5114/aoms/221117}
}
EUVIMED